WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Sees Large Volume Increase – Should You Buy?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw unusually-strong trading volume on Thursday . Approximately 256,992 shares traded hands during mid-day trading, an increase of 265% from the previous session’s volume of 70,444 shares.The stock last traded at $12.30 and had previously closed at $12.54.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, WuXi Biologics (Cayman) has an average rating of “Hold”.

WuXi Biologics (Cayman) Stock Performance

The stock’s 50-day moving average is $11.31 and its 200 day moving average is $9.58.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.

Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.